Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
56,997,524
-
Share change
-
-815,993
-
Total reported value
-
$1,861,511,680
-
Put/Call ratio
-
102%
-
Price per share
-
$32.66
-
Number of holders
-
179
-
Value change
-
-$79,220,734
-
Number of buys
-
85
-
Number of sells
-
100
Institutional Holders of PORTOLA PHARMACEUTICALS INC - COM (PTLA) as of Q1 2018
As of 31 Mar 2018,
PORTOLA PHARMACEUTICALS INC - COM (PTLA) was held by
179 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,997,524 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Partner Fund Management, L.P., Temasek Holdings (Private) Ltd, BlackRock Inc., STATE STREET CORP, FMR LLC, CADIAN CAPITAL MANAGEMENT, LP, KORNITZER CAPITAL MANAGEMENT INC /KS, and FRED ALGER MANAGEMENT INC.
This page lists
179
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.